Skip to main content

Table 1 Basic information of patients

From: Safety and efficacy of percutaneous electrocoagulation haemostasis in the treatment of grade IV haemorrhagic cystitis after allogeneic haematopoietic stem cell transplantation in children: a retrospective analysis

Patient numbers

Gender

Age

(years)

Bladder capacity (ml)

Operative duration (min)

Bleeding (ml)

Blood clot (ml)

Causes of transplantation

Transplant Time (min)

HB preoperative (g/L)

PLT preoperative (109 /L)

Outcome

Postoperative flush time (days)

Time to progression from HC with conservative treatment to severe HC (days)

Efficacy

Efficacy (reoperation)

1

Male

9

300

120

50

200

Acute lymphoblastic leukemia

177

105

114

Died

35

51

CR

 

2

Female

13

420

123

50

300

Acute lymphoblastic leukemia

70

86

78

Cured

3

31

CR

 

3

Male

8

270

150

20

200

Acute myeloid leukaemia

69

67

229

Cured

20

21

PR

CR

4

Male

3

120

125

20

80

Acute lymphoblastic leukemia

76

65

117

Cured

15

50

CR

 

5

Female

12

390

113

10

300

Acute lymphoblastic leukemia

120

88

121

Cured

25

90

CR

 

6

Male

13

420

105

50

200

Acute lymphoblastic leukemia

120

69

67

Died

34

60

PR

CR

7

Male

5

180

56

50

100

Acute myeloid leukaemia

150

58

36

Recovered

27

96

CR

 

8

Female

12

390

31

20

200

Aplastic anemia

150

80

79

Cured

30

30

CR

 

9

Male

5

180

110

30

160

Acute lymphoblastic leukemia

60

93

131

Cured

7

15

CR

 

10

Female

8

270

100

30

200

Acute lymphoblastic leukemia

65

81

116

Cured

11

40

CR

 

11

Male

13

420

75

20

400

Acute myeloid leukaemia

39

86

31

Death

30

7

CR

 

12

Female

4

150

85

20

150

Acute lymphoblastic leukemia

98

112

143

Cured

98

37

CR

 

13

Male

8

270

115

30

200

Acute myeloid leukaemia

114

77

20

Cured

14

7

CR

 

14

Male

7

240

80

30

210

Acute lymphoblastic leukemia

40

97

72

Died

7

20

CR